MedTrace Logo

Glucose Insulin Potassium With Intensive Insulin Therapy and (GIK2) Versus GIK Alone

NCT00965406 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 772

Last updated 2017-05-02

No results posted yet for this study

Summary

The aim of this study is to evaluate the effect of the glucose insulin potassium (GIK) infusion associated with intensive insulin therapy compared to GIK alone and control group in patients presenting to the ED with acute coronary syndrome.

Conditions

  • Acute Coronary Syndrome

Interventions

DRUG

GIK and intensive insulin therapy

GIK infusion (1000 ml of Glucose 10%, 20 UI Insulin, 70 mEq of Potassium) within 24 hours. Intravenous intensive insulin therapy is simultaneously administered according to our protocol in the ED

Sponsors & Collaborators

  • University of Monastir

    lead OTHER

Principal Investigators

  • nouira semir, Prof. · Research Laboratory (LR12SP18) University of Monastir Tunisia

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-08-31
Primary Completion
2013-12-31
Completion
2014-06-30

Countries

  • Tunisia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00965406 on ClinicalTrials.gov